Hypertension drug developer Mineralys Therapeutics files for $100M IPO

Jan. 18, 2023 9:21 PM ETMineralys Therapeutics, Inc. (MLYS), SQRXBy: Val Kennedy, SA News Editor1 Comment

Initial Public Offering. IPO. Financial trade. Investment

Andranik Hakobyan

Hypertension drug developer Mineralys Therapeutics (MLYS) has filed for a $100M initial public offering.

The biotech company didn't specify in its filing the price or number of shares to be offered, but indicated in its filing

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.